Kehoe Law Firm, P.C. is investigating securities claims on behalf of investors of Septerna, Inc. (“Septerna” or the “Company”) (NASDAQ: SEPN).
On February 18, 2025, Septerna announced “. . . its decision to discontinue the Phase 1 single- and multiple-ascending dose (SAD/MAD) clinical trial of SEP-786 in healthy volunteers. SEP-786 is an oral small molecule agonist of the parathyroid hormone 1 receptor (PTH1R) being developed for the treatment of hypoparathyroidism.”
The Company also stated that “Septerna’s decision follows the observation of two unanticipated severe (Grade 3) events of elevated unconjugated bilirubin in the MAD portion of the Phase 1 trial, both of which were without elevations in ALT, AST, and GGT liver enzyme levels.”
On this news, Septerna stock dropped more than 65% during pre-market trading on February 18, 2025.
Septerna Investors With Significant Financial Losses: Learn More About the Securities Investigation and Potential Legal Options
If you invested in Septerna stock and want to learn more about the investigation or discuss potential legal claims, please send us a message or contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], for a free, no-obligation legal evaluation.
Septerna investors can also provide details about their investment holdings by completing our Securities Questionnaire.
About Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is a nationally recognized, premier plaintiff-side class action firm dedicated to protecting investors and consumers from corporate misconduct. With a proven track record in litigation, our attorneys have served as Lead or Co-Lead Counsel in cases recovering over $10 billion on behalf of institutional and individual investors and consumers. We advocate and fight for justice in securities fraud, antitrust violations, consumer protection, employment law, data breaches, and whistleblower claims–holding corporations and executives accountable for their wrongdoing. At Kehoe Law Firm, we combine deep legal expertise with a reputation for excellence and results-driven outcomes.
Our class action legal services are on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.
